Renaissance Technologies - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 181 filers reported holding TRANSMEDICS GROUP INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q2 2024$19,866,627
+421070.8%
131,899
+106.7%
0.03%
+385.7%
Q1 2024$4,717
+411.1%
63,799
+445.3%
0.01%
+600.0%
Q4 2023$923
-33.4%
11,699
-53.8%
0.00%
-50.0%
Q3 2023$1,385
-77.3%
25,299
-65.2%
0.00%
-77.8%
Q2 2023$6,114
+27.7%
72,799
+15.2%
0.01%
+50.0%
Q1 2023$4,786
-99.9%
63,199
-38.6%
0.01%0.0%
Q3 2022$4,299,000102,9990.01%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2022
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 65,035$9,795,5725.64%
Sandhill Capital Partners LLC 434,974$65,515,7165.02%
APIS CAPITAL ADVISORS, LLC 40,000$6,024,8004.45%
NEXT CENTURY GROWTH INVESTORS LLC 336,397$50,668,1164.21%
First Light Asset Management, LLC 300,600$45,276,3723.97%
Bullseye Asset Management LLC 49,000$7,3803.61%
Eagle Health Investments LP 132,861$20,011,5243.51%
First Turn Management, LLC 139,780$21,053,6643.42%
Eventide Asset Management 1,145,430$172,524,6672.95%
Montanaro Asset Management Ltd 104,250$15,702,1352.93%
View complete list of TRANSMEDICS GROUP INC shareholders